Not logged in.png)
Share.png)
SaveShare Save Share Save Share Save Fecal microbiota transplantation plus immune checkpoint inhibitor rechallenges in patients with advanced non-small cell lung cancer: a single-arm exploratory study
Du, Yijia; Li, Yanying; Yu, Min; Yu, Yang; Zhang, Yan; Wang, Xianfeng; He, Jianquan; Lin, Lin; Shen, Baolong; Gong, Youling; Zhu, Jiang; Zou, Bingwen; Liu, Yongmei; Huang, Meijuan; Lu, You Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save Four-year outcomes from GEMSTONE-302 study: First-line sugemalimab plus platinum-based chemotherapy in metastatic non-small cell lung cancer (NSCLC)Zhou, C.; Wang, Z.; Sun, M.; Cao, L.; Ma, Z.; Wu, R.; Yu, Y.; Yao, W.; Sun, S.; Chen, J.; Zhuang, W.; Cui, J.; Chen, X.; Lu, Y.; Hu, C.; Wang, J.; Wang, Q.; Wang, B.; Dai, H.; Yang, J. J. Share Save Metformin prevents the onset and progression of intervertebral disc degeneration: New insights and potential mechanisms (Review)Yang, Wenzhi; Yang, Yipin; Wang, Yong; Gao, Zongshi; Zhang, Jingtang; Gao, Weimin; Chen, Yanjun; Lu, You; Wang, Haoyu; Zhou, Lingyan; Wang, Yifan; Li, Jie; Tao, Hui Share Save AdvanTIG-204: A phase 2, multicenter, randomized, 3-arm, open-label study investigating the preliminary efficacy and safety of ociperlimab (anti-TIGIT) plus tislelizumab (anti-PD-1) + concurrent chemoradiotherapy (cCRT) in patients with untreated limited-stage small cell lung cancer (SCLC)Gong, Youling; Pang, Qingsong; Yu, Rong; Zhu, Zhengfei; Huang, Jiangqiong; Cheng, Yufeng; Zhong, Diansheng; Wu, Hongbo; Yoo, Seung Soo; Dobbs, Tracy; Bao, Zinan; Zuo, Yunxia; Wei, Boxian; Sun, Pu; Lu, You Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png)
CANCER RESEARCH.png)
